The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510000, China
NCT Number: NCT03568747
Exertional dyspnea is a major cause of exercise limitation and anxiety, and contributes importantly to reduced quality of life for patients with COPD. The aim of this study is to determine the efficacy and mechanism of NIV with a dual-limb circuit plus oxygen therapy in relieving exertional dyspnea in patients with severe COPD, so as to provide a guidance for clinical use for NIV.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Guangzhou, Guangdong, 510000, China
Exertional dyspnea was the most characteristic respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD), it is a major cause of exercise limitation and anxiety, and contributes importantly to reduced quality of life for patients with COPD. COPD patients often unconsciously adopt a sedentary lifestyle, probably due to distressing exertional dyspnea. The sedentarism results in physical deconditioning and alterations of the peripheral muscles, which leads to a vicious circle and contribute to the debilitation of the patients. Thereby, intervention should be taken to intervene this vicious cycle. It has been reported that noninvasive ventilation (NIV) could help unload the inspiratory muscle, improve dynamic pulmonary hyperinflation, improve neuro-mechanical coupling, oxygenation, and thus relieved dyspnea during exercise in COPD patients. However, in these reports, NIV was used as add-on therapy during exercise or at resting condition before exertional dyspnea occurred. So far, there's few studies on the efficacy of NIV used at the time of exertional dyspnea occurred as the rescue therapy to relieve dyspnea after exercise in patients with stable severe COPD while the patients are already undergoing optimal treatment with bronchodilator and anti-inflammatory medication, which might relieve their physiological and perceptional burden to limit their activities. The result of the investigators previous study has suggested that compared with oxygen therapy, NIV plus oxygen therapy resulted in decrease in dyspnea intensity at isotime, however, there's no statistically significant shortening in total dyspnea recovery time and NIV was not helpful in all the COPD patients. In another study, it was indicated that ventilated by a single-limb tubing with a plateau exhalation valve (PEV) caused CO2 rebreathing to COPD patients during exercise. CO2 rebreathing may have a negative impact on efficacy. Previous studies have proved that exercise tolerance was improved ventilated by noninvasive ventilation with a dual-limb circuit. In theory, NIV with a dual-limb circuit consists of one inhalation limb that introduces air into the patient's airways and one exhalation limb that leads exhaled gas outside of the airways, there is no risk of rebreathing. However, it is unclear whether NIV with a dual-limb circuit could be used at the time of exertional dyspnea occurred as rescue therapy to relieve dyspnea after exercise in patients with stable severe COPD and what are the mechanisms. The purpose of this study was therefore to determine whether assisted with NIV with dual-limb circuit in patients with stable severe COPD after exercise with exertional dyspnea (1)dyspnea was relieved after exercise in patients with stable severe COPD; (2)the repiratory mechanism.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
dual-limb circuit NIV were given on maquet servo i apparatus
oxygen therapy were introduced to the side port of the facemask
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
this is a scale that asks the participants to rate the difficulty of breathing. It starts at number 0 where one's breathing is causing no difficulty at all and progresses through to number 10 where one's breathing difficulty is maximal.
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
EMGdi
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
EMGdi%max:Vt%VCpred
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Pdi
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Pes
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Pm
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
IC
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
VE
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
SpO2
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
HR
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
total recovery time
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Vt
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
RR
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Ti
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Ttot
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
Te
Time frame: baseline, at peak exercise and at every 30s interval until complete recovery
PTP
Guangzhou Institute of Respiratory Disease
Other
Efficacy and Mechanism of Non-invasive Ventilation in Relieving Dyspnea After Exercise in Patients With Stable Severe Chronic Obstructive Pulmonary Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04709562
Acid-Base Imbalance, Acidosis
Los Angeles, California, United States
View Trial DetailsNCT06432920
Chronic Disease, Chronic Obstructive Pulmonary Disease
Sandyford, Dublin 18, Ireland
View Trial DetailsNCT02720822
Chronic Disease, Chronic Obstructive Pulmonary Disease
Canberra, Australian Capital Territory, Australia
View Trial DetailsNCT03467815
Chronic Disease, Chronic Obstructive Pulmonary Disease
Copenhagen, Denmark
View Trial Details